you are here:

Glenmark Pharma Ltd.

BSE: 532296 | NSE: GLENMARK |

Represents Equity.Intra - day transactions are permissible and normal trading is done in this category
Series: EQ | ISIN: INE935A01035 | SECTOR: Pharmaceuticals

BSE Live

Apr 19, 16:00
578.95 7.05 (1.23%)
Volume
AVERAGE VOLUME
5-Day
510,824
10-Day
369,950
30-Day
186,810
700,012
  • Prev. Close

    571.90

  • Open Price

    572.00

  • Bid Price (Qty.)

    577.55 (62)

  • Offer Price (Qty.)

    578.95 (247)

NSE Live

Apr 19, 15:59
578.90 7.00 (1.22%)
Volume
AVERAGE VOLUME
5-Day
9,503,502
10-Day
6,493,223
30-Day
3,167,242
13,615,161
  • Prev. Close

    571.90

  • Open Price

    570.00

  • Bid Price (Qty.)

    0.00 (0)

  • Offer Price (Qty.)

    578.90 (3280)

Financials

2020 2019 2018 2017 2016
Nine Months Results of Glenmark Pharma (in Rs. Cr.) Dec '20 Dec '19 Dec '18 Dec '17 Dec '16  
Net Sales/Income from operations 5,717.57 5,104.90 4,600.38 4,589.73 5,756.27  
Other Operating Income -- -- 117.21 174.41 274.14  
Total Income From Operations 5,717.57 5,104.90 4,717.59 4,764.14 6,030.41  
EXPENDITURE  
Consumption of Raw Materials 2,032.41 1,702.34 1,330.96 1,507.31 1,694.14  
Purchase of Traded Goods 231.92 281.63 253.61 224.91 210.96  
Increase/Decrease in Stocks -31.31 -3.12 154.93 17.11 -83.62  
Power & Fuel -- -- -- -- --  
Employees Cost 855.47 829.93 745.75 789.59 693.35  
Depreciation 113.82 103.31 79.93 88.39 77.62  
Excise Duty -- -- -- -- --  
Admin. And Selling Expenses -- -- -- -- --  
R & D Expenses -- -- -- -- --  
Provisions And Contingencies -- -- -- -- --  
Exp. Capitalised -- -- -- -- --  
Other Expenses 1,094.74 1,191.40 1,173.60 1,208.02 1,289.04  
P/L Before Other Inc. , Int., Excpt. Items & Tax 1,420.52 999.41 978.80 928.81 2,148.93  
Other Income 279.38 355.50 307.23 136.12 198.49  
P/L Before Int., Excpt. Items & Tax 1,699.90 1,354.91 1,286.02 1,064.93 2,347.42  
Interest 203.39 192.82 171.21 140.18 102.88  
P/L Before Exceptional Items & Tax 1,496.51 1,162.09 1,114.82 924.76 2,244.54  
Exceptional Items 73.89 -- 345.19 -- --  
P/L Before Tax 1,570.40 1,162.09 1,460.00 924.76 2,244.54  
Tax 262.73 156.73 252.99 131.92 458.60  
P/L After Tax from Ordinary Activities 1,307.68 1,005.36 1,207.02 792.84 1,785.94  
Prior Year Adjustments -- -- -- -- --  
Extra Ordinary Items -- -- 133.81 -- --  
Net Profit/(Loss) For the Period 1,307.68 1,005.36 1,340.82 792.84 1,785.94  
Equity Share Capital 28.22 28.22 28.22 28.22 28.22  
Reserves Excluding Revaluation Reserves -- -- -- -- --  
Equity Dividend Rate (%) -- -- -- -- --  
EPS Before Extra Ordinary  
Basic EPS 46.34 35.63 47.52 28.10 63.29  
Diluted EPS 46.34 35.63 47.52 28.09 63.28  
EPS After Extra Ordinary  
Basic EPS. 46.34 35.63 47.52 28.10 63.29  
Diluted EPS. 46.34 35.63 47.52 28.09 63.28  
Public Share Holding  
No Of Shares (Crores) -- -- -- -- --  
Share Holding (%) -- -- -- -- --  
Promoters and Promoter Group Shareholding  
a) Pledged/Encumbered  
- Number of shares (Crores) -- -- -- -- --  
- Per. of shares (as a % of the total sh. of prom. and promoter group) -- -- -- -- --  
- Per. of shares (as a % of the total Share Cap. of the company) -- -- -- -- --  
b) Non-encumbered  
- Number of shares (Crores) -- -- -- -- --  
- Per. of shares (as a % of the total sh. of prom. and promoter group) -- -- -- -- --  
- Per. of shares (as a % of the total Share Cap. of the company) -- -- -- -- --  
Source : Dion Global Solutions Limited